ARTICLE | Clinical News
Alexion preclinical data
November 1, 1999 8:00 AM UTC
ALXN researchers and colleagues presented data from monkeys in which 5G1.1 increased the acceptance of transplanted fetal pig dopaminergic neurons. 5G1.1 is in Phase II testing to treat rheumatoid arthritis and membranous nephritis. Data were presented at the Society for Neuroscience meeting in Miami Beach. ...